Mineralys Therapeutics, Inc. Share Price
Equities
MLYS
US6031701013
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.84 USD | -0.66% | -10.09% | +48.14% |
09/05 | Transcript : Mineralys Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Mineralys Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 642M 53.59B |
---|---|---|---|---|---|
Net income 2024 * | -142M -11.85B | Net income 2025 * | -173M -14.44B | EV / Sales 2024 * | - |
Net cash position 2024 * | 105M 8.81B | Net cash position 2025 * | 137M 11.45B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.32
x | P/E ratio 2025 * |
-4.03
x | Employees | 28 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.63% |
Latest transcript on Mineralys Therapeutics, Inc.
1 day | -0.66% | ||
1 week | -10.09% | ||
Current month | +4.00% | ||
1 month | +3.24% | ||
3 months | -12.38% | ||
6 months | +78.18% | ||
Current year | +48.14% |
Managers | Title | Age | Since |
---|---|---|---|
Jon Congleton
CEO | Chief Executive Officer | 60 | 01/20/01 |
Adam Levy
DFI | Director of Finance/CFO | 46 | 01/22/01 |
Jessica Ibbitson
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 01/21/01 | |
Glenn Sblendorio
BRD | Director/Board Member | 68 | 13/23/13 |
Director/Board Member | 58 | 01/21/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.48% | - |
Date | Price | Change | Volume |
---|---|---|---|
14/24/14 | 12.74 | -1.47% | 25 626 |
13/24/13 | 12.93 | -4.36% | 127,537 |
10/24/10 | 13.52 | -5.26% | 121,642 |
09/24/09 | 14.27 | -2.59% | 189,561 |
08/24/08 | 14.65 | +3.39% | 277,799 |
Delayed Quote Nasdaq, May 14, 2024 at 10:21 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.14% | 642M | |
+28.30% | 48.16B | |
-1.01% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.12% | 25.59B | |
-22.72% | 18.96B | |
+8.29% | 12.92B | |
+29.02% | 12.03B | |
-2.11% | 11.77B |
- Stock Market
- Equities
- MLYS Stock